MENU
LUMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lumos Pharma (LUMO) Ownership - Who owns Lumos Pharma?
Profile
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 512 215-2630
Employees
33
Web
https://www.lumos-pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.54M
P/E Ratio
N/A
Total Cash
13.52M
Projected Growth
N/A
Total Debt
172K
Revenue
2.21M
Risk (Beta)
-0.43
Dividend Yield
N/A
Total Cash/Share
1.56
Total Debt/Equity
N/A
Revenue/Share
0.27 USD as % of share price
Fundamentals
LUMO
Capitalization
37.5M
P/E Ratio
N/A
Risk (Beta)
-0.43
Dividend Yield
N/A
Total Cash
13.5M
Total Cash/Share
1.56
Total Debt
172K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.27%
Revenue
2.21M
ROE
N/A
Book Value
4.91M
P/B Ratio
7.64
Cash Flow
N/A
Earnings
-4.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
86K
Current Ratio
2.66
Current Revenue Per Employee
24200.00
Dividends Per Share - Security
N/A
EBITDA
-36.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-107.08
Shares Held By Institutions
9.59M
Shares Outstanding - Current
8.65M
Total Liabilities
12.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
36.478
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which engages in the development of therapeutics for the treatment of Pediatric Growth Hormone Deficiency (PGHD)
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 512 215-2630
Employees
33
Web
https://www.lumos-pharma.com